摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-((2-(3-(trifluoromethyl)phenyl)hydrazinylidene)methyl)-N'-((E)-3-phenylallylidene)quinoline-4-carbohydrazide | 1386874-83-4

中文名称
——
中文别名
——
英文名称
2-((2-(3-(trifluoromethyl)phenyl)hydrazinylidene)methyl)-N'-((E)-3-phenylallylidene)quinoline-4-carbohydrazide
英文别名
——
2-((2-(3-(trifluoromethyl)phenyl)hydrazinylidene)methyl)-N'-((E)-3-phenylallylidene)quinoline-4-carbohydrazide化学式
CAS
1386874-83-4
化学式
C27H20F3N5O
mdl
——
分子量
487.484
InChiKey
JVIFXTXOXIAKLO-MNPLUXTLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.13
  • 重原子数:
    36.0
  • 可旋转键数:
    7.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.04
  • 拓扑面积:
    78.74
  • 氢给体数:
    2.0
  • 氢受体数:
    5.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    参考文献:
    名称:
    Discovery of Novel Small Molecule Inhibitors of Dengue Viral NS2B-NS3 Protease Using Virtual Screening and Scaffold Hopping
    摘要:
    By virtual screening, compound 1 was found to be active against NS2B-NS3 protease (IC50 = 13.12 +/- 1.03 mu M). Fourteen derivatives (22) of compound 1 were synthesized, leading to the discovery of four new inhibitors with biological activity. In order to expand the chemical diversity of the inhibitors, small-molecule-based scaffold hopping was performed on the basis of the common scaffold of compounds 1 and 22. Twenty-one new compounds (23, 24) containing quinoline (new scaffold) were designed and synthesized. Protease inhibition assays revealed that 12 compounds with the new scaffold are inhibitors of NS2B-NS3 protease. Taken together, 17 new compounds were discovered as NS2B-NS3 protease inhibitors with IC50 values of 7.46 +/- 1.15 to 48.59 +/- 3.46 mu M, and 8 compounds belonging to two different scaffolds are active to some extent against DENY based on luciferase reporter replicon-based assays. These novel chemical entities could serve as lead structures for discovering therapies against DENY.
    DOI:
    10.1021/jm300146f
点击查看最新优质反应信息